NLRP3-IN-20 is an effective oral inhibitor of NLRP3 inflammatory corpuscles, and the IC50 secreted by IL-1beta is 25nM. NLRP3-IN-20 showed good pharmacokinetic characteristics, and showed significant pharmacological activities in animal models such as nonalcoholic steatohepatitis, septic shock and colitis.
Molekulargewicht:
413.53
CAS Nummer:
[2428478-22-0]
Formel:
C22H27N3O3S
Target-Kategorie:
NOD-like Receptor (NLR)
T79733
T79733
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
